Conference Coverage
Conference Coverage
Twenty years and counting: Tamoxifen’s lasting improvement in breast cancer
Study suggests long-term improvement for some women with breast cancer.
Conference Coverage
Uninformed breast cancer patients are making treatment decisions
Clouded by the thought “I have breast cancer,” patients are making uninformed treatment decisions.
Conference Coverage
Misconceptions remain on gene signature use in breast cancer
The “misconception regarding the predictive value of these tests on chemotherapy benefits suggest there is still room for training on results...
Conference Coverage
Recurrent DCIS can be genetically distinct from primary lesion
Findings may change how breast cancer patients are treated.
Conference Coverage
1 in 7 breast cancer patients report worsening personal finances
New survey doesn’t find a link between money woes and stage of disease or treatment.
Conference Coverage
Omega-3 fatty acids linked to less FOXA1 in benign breast tissue
Findings suggest transcription factor could be a helpful biomarker in cancer prevention trials.
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
News
Aspirin fails to inhibit breast cancer recurrence
Aspirin has been proven effective in reducing colon cancer recurrence rates, but this new randomized, controlled trial contradicts epidemiological...
News
Cost not a factor in radiotherapy type for breast cancer patients
“Hypofractionated radiotherapy represents significant savings to both the health care system and to individual patients. It may soon become the...
News
Breast cancer treatment worse for incarcerated patients
Breast cancer patients who are incarcerated at diagnosis often do not get neoadjuvant therapy and face delays in upfront surgery, study finds.